T7	Drug 79 98	anetumab ravtansine
E2	Drug:T7 Name:T8
T8	Drug-Name 79 98	anetumab ravtansine
T9	Study 106 111	study
E4	Study:T9 Study-Of:E2
T1	Procedure 166 175	treatment
E1	Procedure:T1 Temporality:E3
T2	Eq-Comparison 163 165	on
E3	Eq-Comparison:T2 Temporal-Period:T3
T3	Eq-Temporal-Period 163 165	on
A1	Eq-Temporal-Period-Value T3 present
T4	Drug 248 260	intervention
E5	Drug:T4 
T5	Study 242 247	study
E6	Study:T5 Study-Of:E5
T6	Assertion 205 213	eligible
E7	Assertion:T6 Asserted:E5
A2	Assertion-Type-Value E7 hypothetical
R1	If-Then Arg1:E1 Arg2:E5	
T10	Observation 359 379	serum pregnancy test
E8	Observation:T10 Name:T11 Polarity:T12
T11	Observation-Name 359 379	serum pregnancy test
A3	Observation-Type-Value T11 lab
T12	Polarity 350 358	positive
A4	Polarity-Value T12 positive
T13	Procedure 324 333	treatment
E9	Procedure:T13 Temporality:E10
T14	Eq-Comparison 321 323	on
E10	Eq-Comparison:T14 Temporal-Period:T15
T15	Eq-Temporal-Period 321 323	on
A5	Eq-Temporal-Period-Value T15 present
R2	If-Then Arg1:E9 Arg2:E8	
T16	Procedure 393 402	treatment
E11	Procedure:T16 Temporality:E12
T17	Eq-Comparison 390 392	on
E12	Eq-Comparison:T17 Temporal-Period:T18
T18	Eq-Temporal-Period 390 392	on
A6	Eq-Temporal-Period-Value T18 present
T19	Drug 454 465	medications
E13	Drug:T19 Minimum-Count:E14
T20	Eq-Comparison 424 435	one or more
E14	Eq-Comparison:T20 Value:T21 Operator:T22
T21	Eq-Value 424 427	one
T22	Eq-Operator 428 435	or more
A7	Eq-Operator-Value T22 GTEQ
R3	If-Then Arg1:E11 Arg2:E13	
T23	Drug 584 603	anetumab ravtansine
E15	Drug:T23 Name:T24
T24	Drug-Name 584 603	anetumab ravtansine
T25	Negation 580 583	not
E16	Negation:T25 Negates:E15
T26	Eq-Comparison 540 549	receiving
E17	Eq-Comparison:T26 Temporal-Period:T27
T27	Eq-Temporal-Period 540 549	receiving
A8	Eq-Temporal-Period-Value T27 present
T28	Drug 567 575	agent(s)
E18	Drug:T28 Temporality:E17
T29	And 576 579	but
E19	And:T29 Arg:E18 Arg2:E16
T30	Study 696 701	study
E20	Study:T30 Study-Of:E22
T31	Other 672 679	outside
E21	Other:T31 Is-Other:E20
T32	Drug 666 671	agent
E22	Drug:T32 
T33	Assertion 633 640	able to
E23	Assertion:T33 Asserted:E22
A9	Assertion-Type-Value E23 hypothetical
T34	And 625 628	and
E24	And:T34 Arg:E18 Arg2:E23
